MedPath

Spirulina plantensis supplementation reduces anemia, inflammation and improve nutritional status of sickle cell aneamia patients

Not Applicable
Conditions
Haematological Disorders
Registration Number
PACTR202211821139161
Lead Sponsor
PIEME Constant Anatole
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
All
Target Recruitment
140
Inclusion Criteria

Will be included in this study
1-Homozygote (SS) and heterozygote SC and SF
2- Male or female
3-Aged between 2 – 35 Years old
4- Patients who approve and sign the form

Exclusion Criteria

1-Sickle cell patient whose iron blood level is higher than normal
2-Sickle cell patient who is taking other treatment simultaneously
3- Sickle cell patient who decided to withdraw to the study
4- Sickle cell patient who did not go through the supplementation at least 3 three and half months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.